pyrazines has been researched along with Femoral Fractures in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldock, PA; Kostenuik, PJ; Little, DG; McDonald, MM; Mikulec, K; Morse, A; Peacock, L | 1 |
Jonsson, KB; Larsson, S; Ljunggren, O; Marsell, R; Nilsson, O; Sisask, G; Sundgren-Andersson, A | 1 |
2 other study(ies) available for pyrazines and Femoral Fractures
Article | Year |
---|---|
Matrix metalloproteinase-driven endochondral fracture union proceeds independently of osteoclast activity.
Topics: Animals; Bone Density Conservation Agents; Clodronic Acid; Collagenases; Diphosphonates; Femoral Fractures; Fracture Healing; Humans; Hydroxamic Acids; Imidazoles; Male; Matrix Metalloproteinase Inhibitors; Osteoclasts; Osteoprotegerin; Pyrazines; Rats; Rats, Wistar; Recombinant Proteins; Sulfonamides; Time Factors; Zoledronic Acid | 2013 |
Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bony Callus; Female; Femoral Fractures; Femur; Fracture Healing; Glycogen Synthase Kinase 3; Organ Size; Osteogenesis; Piperazines; Protein Kinase Inhibitors; Pyrazines; Radiography; Rats; Rats, Sprague-Dawley; Sulfonamides | 2013 |